| |
|
|
| Name: |
TANG CAPITAL MANAGEMENT LLC |
| City: |
SAN DIEGO |
| State: |
CA |
| Zip: |
92121 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
40 |
|
View All Holdings |
Currently
Viewing:
Decreased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
ANAB |
Anaptysbio Inc |
4 |
- |
$23.77 |
$29,971,000 |
1,330,879 |
3.12% |
-11,811,000 |
-619,730 |
4.185 |
N/A |
|
|
LLY |
Eli Lilly & Co |
9 |
- |
$878.45 |
$21,005,000 |
27,000 |
2.19% |
3,517,000 |
-3,000 |
0.003 |
Drug Manufacturers - ... |
|
|
PTCT |
PTC Therapeutics, Inc. |
11 |
- |
$35.81 |
$20,363,000 |
700,000 |
2.12% |
-4,441,000 |
-200,000 |
0.773 |
Biotechnology |
|
|
AVDL |
AVADEL Pharmaceuticals Plc |
15 |
- |
$15.99 |
$17,688,000 |
1,047,275 |
1.84% |
2,445,000 |
-32,253 |
1.798 |
Drug Delivery |
|
|
ELEV |
Elevation Oncology, Inc. |
18 |
- |
$3.23 |
$15,698,000 |
3,060,000 |
1.63% |
13,728,000 |
-607,600 |
7.215 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
22 |
- |
$0.00 |
$14,061,000 |
6,450,000 |
1.46% |
3,908,000 |
-100,000 |
9.899 |
N/A |
|
|
LENZ |
Lenz Therapeutics |
25 |
- |
$18.54 |
$12,228,000 |
547,616 |
1.27% |
5,700,000 |
-1,944,164 |
2.145 |
N/A |
|
|
ITCI |
Intra Cellular Therapies Inc |
29 |
- |
$67.77 |
$10,380,000 |
150,000 |
1.08% |
-5,376,000 |
-70,000 |
0.159 |
N/A |
|
|
AZN |
AstraZeneca Plc (ADR) |
32 |
- |
$79.59 |
$10,163,000 |
150,000 |
1.06% |
-1,287,000 |
-20,000 |
0.006 |
Drug Manufacturers - ... |
|
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
33 |
- |
$18.77 |
$9,865,000 |
500,000 |
1.03% |
-659,000 |
-100,000 |
1.412 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
34 |
- |
$0.00 |
$9,732,000 |
571,138 |
1.01% |
1,874,000 |
-200,000 |
1.312 |
N/A |
|
|
BDTX |
Black Diamond Therapeutics,... |
40 |
- |
$5.97 |
$8,128,000 |
1,603,200 |
0.85% |
3,061,000 |
-200,000 |
3.105 |
N/A |
|
|
DTIL |
Precision Biosciences Inc |
41 |
- |
$11.12 |
$7,995,000 |
589,569 |
0.83% |
6,754,000 |
-2,810,431 |
0.532 |
N/A |
|
|
CRSP |
Crispr Therapeutics Ag |
43 |
- |
$63.56 |
$7,941,000 |
116,500 |
0.83% |
-5,518,000 |
-98,500 |
0 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
42 |
- |
$0.70 |
$7,941,000 |
264,692 |
0.83% |
2,697,000 |
-239,550 |
1.951 |
N/A |
|
|
IOVA |
Iovance Biotherapeutics Inc |
46 |
- |
$8.16 |
$7,410,000 |
500,000 |
0.77% |
-720,000 |
-500,000 |
0.234 |
N/A |
|
|
CYTK |
Cytokinetics Inc |
48 |
- |
$53.93 |
$7,011,000 |
100,000 |
0.73% |
-2,173,000 |
-10,000 |
0.082 |
Biotechnology |
|
|
IONS |
Ionis Pharmaceuticals Inc |
50 |
- |
$40.65 |
$6,503,000 |
150,000 |
0.68% |
-3,615,000 |
-50,000 |
0.105 |
Drug Manufacturers - ... |
|
|
VSTM |
Verastem, Inc. |
51 |
- |
$3.47 |
$6,390,000 |
541,514 |
0.67% |
354,000 |
-200,000 |
2.146 |
Biotechnology |
|
|
BGNE |
Beigene Ltd |
54 |
- |
$162.58 |
$5,786,000 |
37,000 |
0.6% |
-9,545,000 |
-48,000 |
0.041 |
N/A |
|
|
BCAB |
Bioatla, Inc. |
59 |
- |
$0.00 |
$5,071,000 |
1,474,076 |
0.53% |
-1,138,000 |
-1,050,000 |
3.197 |
N/A |
|
|
RPHM |
Reneo Pharmaceuticals, Inc. |
60 |
- |
$1.66 |
$4,975,000 |
2,997,000 |
0.52% |
-353,000 |
-333,000 |
8.864 |
N/A |
|
|
BOLT |
Bolt Biotherapeutics, Inc. |
62 |
- |
$0.76 |
$4,788,000 |
3,420,000 |
0.5% |
697,000 |
-232,244 |
9.411 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
65 |
- |
$0.00 |
$3,762,000 |
900,000 |
0.39% |
221,000 |
-166,440 |
1.642 |
N/A |
|
|
CRTX |
Cortexyme, Inc. |
67 |
- |
$0.71 |
$3,125,000 |
2,947,652 |
0.33% |
-256,000 |
-272,348 |
9.992 |
N/A |
|
|
EQC |
Equity Commonwealth |
68 |
- |
$19.22 |
$3,120,000 |
165,261 |
0.32% |
-2,640,000 |
-134,739 |
0.136 |
REIT - Office |
|
|
KNTE |
Kinnate Biopharma Inc. |
72 |
- |
$0.00 |
$2,600,000 |
977,626 |
0.27% |
-3,566,000 |
-1,624,021 |
2.237 |
N/A |
|
|
ATHA |
Athira Pharma, Inc. |
73 |
- |
$0.00 |
$2,336,000 |
852,715 |
0.24% |
-465,000 |
-300,000 |
2.767 |
N/A |
|
|
ADAP |
Adaptimmune Therapeutics PLC |
74 |
- |
$1.01 |
$2,281,000 |
1,443,619 |
0.24% |
-1,198,000 |
-2,943,619 |
0.933 |
N/A |
|
|
AMRN |
Amarin Corp Plc |
75 |
- |
$0.78 |
$2,227,000 |
2,500,000 |
0.23% |
-458,000 |
-586,544 |
0.639 |
Drug Manufacturers - ... |
|
|
PASG |
Passage Bio, Inc. |
78 |
- |
$1.05 |
$2,025,000 |
1,500,000 |
0.21% |
-399,000 |
-900,000 |
3.295 |
N/A |
|
|
NYCB |
New York Community Bancorp Inc |
79 |
- |
$3.05 |
$1,953,000 |
606,600 |
0.2% |
-14,483,000 |
-1,000,000 |
0.084 |
Savings & Loans |
|
|
ALGS |
Aligos Therapeutics, Inc. |
80 |
- |
$0.00 |
$1,617,000 |
1,650,000 |
0.17% |
163,000 |
-539,847 |
2.291 |
N/A |
|
|
ENZ |
Enzo Biochem Inc |
81 |
- |
$1.16 |
$1,600,000 |
1,260,013 |
0.17% |
-763,000 |
-439,987 |
2.631 |
Medical Laboratories ... |
|
|
IFRX |
InflaRx NV |
85 |
- |
$1.56 |
$1,184,000 |
769,065 |
0.12% |
-1,870,000 |
-1,104,688 |
3.285 |
N/A |
|
|
MCRB |
Seres Therapeutics, Inc. |
90 |
- |
$0.71 |
$702,000 |
907,112 |
0.07% |
-1,808,000 |
-885,776 |
0.731 |
N/A |
|
|
QURE |
uniQure B.V. |
91 |
- |
$4.89 |
$696,000 |
133,921 |
0.07% |
-3,366,000 |
-466,079 |
0.301 |
N/A |
|
|
NXTC |
Nextcure, Inc. |
96 |
- |
$0.00 |
$322,000 |
144,520 |
0.03% |
-211,000 |
-323,402 |
0.525 |
N/A |
|
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
97 |
- |
$0.00 |
$284,000 |
100,000 |
0.03% |
-2,660,000 |
-100,000 |
0.148 |
N/A |
|
|
ERAS |
Erasca, Inc. |
98 |
- |
$2.17 |
$206,000 |
100,000 |
0.02% |
-114,000 |
-50,000 |
0.083 |
N/A |
|
